GB Patent

GB1480763A — Pharmaceutical compositions containing steroids

Assigned to Sanofi Aventis France · Expires 1977-07-27 · 49y expired

What this patent protects

1480763 Antiallergic steroid preparations ROUSSEL-UCLAF 29 July 1974 [27 July 1973] 33381/74 Heading A5B [Also in Division C2] Pharmaceutical compositions having antiallergic activity comprise a carrier and a compound of the general formula: wherein R is H or a C 1-18 acyl resid…

USPTO Abstract

1480763 Antiallergic steroid preparations ROUSSEL-UCLAF 29 July 1974 [27 July 1973] 33381/74 Heading A5B [Also in Division C2] Pharmaceutical compositions having antiallergic activity comprise a carrier and a compound of the general formula: wherein R is H or a C 1-18 acyl residue of an aliphatic, cycloaliphatic or aryl carboxylic acid, the preferred compound being the 21- acetyloxy compound. The compositions may be in conventional forms for oral, buccal, parenteral and rectal administration and may contain conventional diluents and excipients.

Drugs covered by this patent

Patent Metadata

Patent number
GB1480763A
Jurisdiction
GB
Classification
—
Expires
1977-07-27
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis France
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.